title: Dabigatran.
authors.forename: L
authors.initials: L
authors.lastname: Murphy
authors.forename: L
authors.initials: L
authors.lastname: Lawler
authors.forename: E C
authors.initials: EC
authors.lastname: Kavanagh
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D019645:Arthroplasty, Replacement, Knee / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D000069604:Dabigatran; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D054556:Venous Thromboembolism / Q000209:etiology* / Q000517:prevention & control*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D015091:beta-Alanine; D000069604:Dabigatran
references.citation: Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S
references.pmid: 19648146